<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
  dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml"
    tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Endocr Connect</journal-id>
      <journal-id journal-id-type="iso-abbrev">Endocr Connect</journal-id>
      <journal-id journal-id-type="hwp">EC</journal-id>
      <journal-title-group>
        <journal-title>Endocrine Connections</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2049-3614</issn>
      <publisher>
        <publisher-name>Bioscientifica Ltd</publisher-name>
        <publisher-loc>Bristol</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">37768006</article-id>
      <article-id pub-id-type="pmc">PMC10620460</article-id>
      <article-id pub-id-type="doi">10.1530/EC-23-0245</article-id>
      <article-id pub-id-type="publisher-id">EC-23-0245</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Is ongoing testosterone required after pubertal induction in Duchenne
          muscular dystrophy?</article-title>
        <alt-title alt-title-type="lrh">C L Wood et al.</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid" authenticated="true">
            http://orcid.org/0000-0002-6084-5174</contrib-id>
          <name>
            <surname>Wood</surname>
            <given-names>Claire L</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="cor1" ref-type="corresp" />
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hollingsworth</surname>
            <given-names>Kieren G</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bokaie</surname>
            <given-names>Edrina</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hughes</surname>
            <given-names>Eric</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Muni-Lofra</surname>
            <given-names>Robert</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mayhew</surname>
            <given-names>Anna</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mitchell</surname>
            <given-names>Rod T</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guglieri</surname>
            <given-names>Michela</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McElvaney</surname>
            <given-names>Joseph</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cheetham</surname>
            <given-names>Timothy D</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="fn1" ref-type="author-notes">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Straub</surname>
            <given-names>Volker</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="aff3" ref-type="aff">3</xref>
          <xref rid="fn1" ref-type="author-notes">*</xref>
        </contrib>
        <aff id="aff1"><label>1</label><institution>Department of Paediatric Endocrinology</institution>
          , <addr-line>Royal Victoria Infirmary, Newcastle upon Tyne, UK</addr-line></aff>
        <aff id="aff2"><label>2</label><institution>Translational and Clinical Research Institute</institution>
          , <addr-line>Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK</addr-line></aff>
        <aff id="aff3"><label>3</label><institution>John Walton Muscular Dystrophy Research Centre</institution>
          , <addr-line>Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle
          upon Tyne, UK</addr-line></aff>
        <aff id="aff4"><label>4</label><institution>MRC Centre for Reproductive Health</institution>
          , <addr-line>The University of Edinburgh, Queens Medical Research Institute, Edinburgh, UK</addr-line></aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Correspondence should be addressed to C L Wood: <email>
          claire.wood@ncl.ac.uk</email>
        </corresp>
        <fn id="fn1">
          <p><sup>*</sup>(T D Cheetham and V Straub contributed equally to this work)</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>26</day>
        <month>10</month>
        <year>2023</year>
      </pub-date>
      <pub-date pub-type="epreprint">
        <day>28</day>
        <month>9</month>
        <year>2023</year>
      </pub-date>
      <pub-date pub-type="collection">
        <day>01</day>
        <month>12</month>
        <year>2023</year>
      </pub-date>
      <volume>12</volume>
      <issue>12</issue>
      <elocation-id>e230245</elocation-id>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>6</month>
          <year>2023</year>
        </date>
        <date date-type="accepted">
          <day>28</day>
          <month>9</month>
          <year>2023</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#x000a9; the author(s)</copyright-statement>
        <copyright-year>2023</copyright-year>
        <copyright-holder>the author(s)</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/"
            specific-use="textmining" content-type="ccbylicense">
            https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p><inline-graphic xlink:href="88x31.jpg" />This work is licensed under a <ext-link
              ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative
            Commons Attribution 4.0 International License.</ext-link></license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:href="EC-23-0245.pdf" />
      <abstract>
        <p>Glucocorticoids (GCs) reduce inflammation and preserve muscle function in boys with
          Duchenne muscular dystrophy (DMD) but cause pubertal delay. Pubertal induction with
          testosterone is recommended but longer-term outcome is unknown.</p>
        <sec>
          <title>Objective</title>
          <p>To assess hypothalamic&#x02013;pituitary&#x02013;gonadal axis, muscle volume and
            function 5 years after pubertal induction.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>A prospective observational follow-up of a clinical study was conducted. 15 GC-treated
            males with DMD were treated with incremental testosterone for 2 years (end of regimen +2
            years) then evaluated at +2.5 years and +5 years (final follow-up ~3 years after last
            injection). Data collected included testicular volume (TV), gonadotrophin, testosterone,
            inhibin B, muscle function, and limb muscle MRI.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Participants were 18.7 years (<sc>s.d.</sc> 1.6) at the final follow-up and had been on
            GC for 11.2 years (<sc>s.d.</sc> 2.2). Testosterone levels were similar at +2.5 years
            (8.6 nmol/L (<sc>s.d.</sc> 3.4) and 5 years (11.0 nmol/L (<sc>s.d.</sc> 6.1). TV
            increased from 2.8 mL (<sc>s.d.</sc> 0.9) at +2 years to 7.1 mL (<sc>s.d.</sc> 1.8) then
            10.6 mL (<sc>s.d.</sc> 3.5) at +2.5 years and +5.0 years (<italic toggle="yes">P</italic>
            &#x0003c; 0.001). Inhibin B levels increased from 55.6 pg/mL (<sc>s.d.</sc> 47.0) at
            baseline to 158.2 pg/mL (<sc>s.d.</sc>87.6), <italic toggle="yes">P</italic> =0.004 at 5
            years but remained lower than reference values (mean 305 pg/mL). Muscle contractile bulk
            decreased.</p>
        </sec>
        <sec>
          <title>Interpretation</title>
          <p>Pubertal induction with testosterone in DMD is associated with HPG axis activation and
            ongoing increases in inhibin B, TV, and testosterone concentrations. Some patients have
            normal levels which is promising regarding future fertility. Given the beneficial impact
            of testosterone on bone health, muscle, and well-being, monitoring testosterone levels
            in this population and supplementation of sub-optimal levels is important.</p>
        </sec>
      </abstract>
      <kwd-group>
        <title>Key Words</title>
        <kwd>puberty</kwd>
        <kwd>Duchenne muscular dystrophy</kwd>
        <kwd>testosterone</kwd>
        <kwd>muscle MRI</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Duchenne muscular dystrophy (DMD) is characterised by the absence of dystrophin protein and
        results in muscle cell fragility, inflammatory change, and the accumulation of fibrotic
        tissue and fat in skeletal muscles (<xref rid="bib1" ref-type="bibr">1</xref>). Despite
        intensive research there is no cure for DMD and long-term high dose glucocorticoids (GCs)
        form the mainstay of treatment. GCs stabilise muscle strength for a period of time and have
        beneficial effects on the heart, lungs and spine (<xref rid="bib2" ref-type="bibr">2</xref>).
        Chronic GC use, however, can result in many adverse effects including pubertal delay. Recent
        work at our centre has shown that incremental monthly testosterone injections can induce
        puberty in adolescents with DMD and delayed puberty (<xref rid="bib3" ref-type="bibr">3</xref>).
        The 2-year testosterone regimen had a positive impact on the skeleton and contractile muscle
        bulk. There was also evidence of a beneficial impact on the underlying disease process, with
        reduced muscle inflammation as detected by a reduced T2 relaxation time on MR spectroscopy.
        Consideration for testosterone treatment for the induction of puberty has recently been
        introduced as part of the International Care Considerations in DMD (<xref rid="bib4"
          ref-type="bibr">4</xref>). It remains unclear what happens to endogenous testosterone
        levels once testosterone supplementation is stopped, particularly in the context of ongoing
        GC therapy. Having shown a beneficial effect of testosterone on muscle, bone, and quality of
        life, it is important to explore whether these young men benefit from ongoing testosterone
        supplementation. There are, in addition, no data regarding spermatogenesis and fertility in
        the adult DMD population, other than anecdotal reports of adults fathering children. This
        study investigates the longer-term outcome and androgen status after pubertal induction with
        testosterone administered as part of a clinical trial (NCT02571205).</p>
    </sec>
    <sec>
      <title>Patients and methods</title>
      <p>Participants were invited to take part in this observational follow-up study if they had
        been enrolled in the initial single-centre study that followed 15 prepubertal males with DMD
        who were aged between 12 and 17 years old. All were treated with a 2-year incremental
        regimen of 4-weekly testosterone injections (NCT02571205). Full details of the clinical
        trial have been published (<xref rid="bib3" ref-type="bibr">3</xref>, <xref rid="bib5"
          ref-type="bibr">5</xref>). In this current study, the primary objective was to assess key
        components of hypothalamo&#x02013;pituitary&#x02013;gonadal (HPG) function following
        completion of the course of testosterone injections. The outcome measures in this
        observational follow-up study were therefore clinical and biochemical markers of HPG
        activity including inhibin B concentrations. The initial intention was to follow the
        participants on two further occasions, at 1 and 2 years after that visit. However, as a
        result of the coronavirus disease 2019 (COVID-19) pandemic and patients with DMD being
        required to shield, these visits could not be completed as planned. They were evaluated at 6
        months after last injection as part of their clinical care and subsequently attended a final
        follow-up visit at a mean of 2.8 years (<sc>s.d</sc>. 0.40) after final injection. For the
        purposes of clarity, these timepoints are as follows:</p>
      <list list-type="bullet">
        <list-item>
          <p>Baseline (0 years, at initiation of testosterone regimen)</p>
        </list-item>
        <list-item>
          <p>End of regimen (after 2 years of testosterone treatment or timepoint +2.0 years)</p>
        </list-item>
        <list-item>
          <p>6 months after testosterone treatment completed (2.5 years from baseline or timepoint
            +2.5 years)</p>
        </list-item>
        <list-item>
          <p>Final follow-up (3 years after finishing testosterone treatment and 5 years from
            baseline or timepoint +5.0 years)</p>
        </list-item>
      </list>
      <p>The outcome measures were as follows:</p>
      <list list-type="bullet">
        <list-item>
          <p>Auxological assessment including height, weight, Tanner staging of pubertal status,
            testicular volumes (reported as mean values)</p>
        </list-item>
        <list-item>
          <p>Biochemical assessment of androgen status</p>
        </list-item>
        <list-item>
          <p>Bone age x-ray (using left wrist)</p>
        </list-item>
        <list-item>
          <p>Muscle cross-sectional area (CSA), contractile cross-sectional area (cCSA), fat
            fraction (FF), and T2 relaxation time (upper limb only) determined by muscle MRI of
            upper and lower limbs, motor performance evaluated using North Star Ambulatory
            Assessment (NSAA) and / or Performance of Upper Limb (PUL 2.0)</p>
        </list-item>
        <list-item>
          <p>Bone mineral adjusted density of the lumbar spine and total body (minus head) and body
            composition using dual-energy x-ray absorptiometry (DXA)</p>
        </list-item>
      </list>
      <sec>
        <title>Clinical assessment</title>
        <p>Height and weight were measured using a stadiometer. Subjects who were unable to stand
          with their heels flat or who lost standing ability during the course of the follow-up had
          arm span recorded instead and used as a surrogate for height. For further information,
          please refer to the published protocol (<xref rid="bib5" ref-type="bibr">5</xref>).
          Testicular size was assessed using a Prader orchidometer and pubertal staging determined
          using Tanner staging criteria (<xref rid="bib6" ref-type="bibr">6</xref>). The bilateral
          testicular volume was calculated using the sum of the left&#x02009;+&#x02009;right
          volumes.</p>
      </sec>
    </sec>
    <sec>
      <title>Biochemical gonadal/androgen status</title>
      <p>Biochemical pubertal status was determined by measuring markers of the following:</p>
      <list list-type="order">
        <list-item>
          <p>Leydig cell function &#x02013; morning (pre-10:00 h) serum testosterone</p>
        </list-item>
        <list-item>
          <p>Sertoli cell function &#x02013; anti-Mullerian hormone (AMH) and inhibin B levels,
            which were analysed by ELISA after transportation to the Protein Reference Unit in
            Sheffield</p>
        </list-item>
        <list-item>
          <p>Gonadotrophin function &#x02013; luteinising hormone (LH) and follicle-stimulating
            hormone (FSH) concentrations as previously described (<xref rid="bib5" ref-type="bibr">5</xref>
            )</p>
        </list-item>
      </list>
      <sec>
        <title>Bone age</title>
        <p>Bone age was assessed using a radiograph of the left wrist that was then reported by a
          radiologist using the Greulich and Pyle method (<xref rid="bib7" ref-type="bibr">7</xref>
          ).</p>
      </sec>
      <sec>
        <title>Motor function and muscle strength</title>
        <p>All participants performed PUL (Version 2.0) for assessing upper limb performance (<xref
            rid="bib8" ref-type="bibr">8</xref>) and ambulatory patients also undertook the North
          Star Ambulatory Assessment for DMD (NSAA) (<xref rid="bib9" ref-type="bibr">9</xref>).</p>
      </sec>
      <sec>
        <title>Bone mineral density</title>
        <p>DXA scans were conducted using a Lunar iDXA (GE Lunar Corp, Madison, WI, USA) to assess
          lean vs total body mass (lean and fat mass combined) and enable calculation of bone
          mineral content (BMC), adjusted for age, size, and gender.</p>
        <p>The patient&#x02019;s height measured in the clinic visit (as detailed above) was used
          for size adjustment. Predicted lean body mass (LBM) for height was adjusted for sex and
          estimated Tanner stage. Stepwise linear regression was used with published reference
          ranges to obtain age, size and sex adjusted adjusted <italic toggle="yes">Z</italic>-scores
          for total body (minus head) BMC and Lumbar spine (L2-4) BMC for LBM (<xref rid="bib10"
            ref-type="bibr">10</xref>).</p>
      </sec>
      <sec>
        <title>MRI data acquisition and image processing</title>
        <p>Imaging was performed on a 3.0 Tesla scanner (for detailed methods, see section on
          supplementary data given at the end of this article). Briefly, quantitative Dixon FF
          imaging was collected using fivefold compressed sensing acceleration (<xref rid="bib11"
            ref-type="bibr">11</xref>, <xref rid="bib12" ref-type="bibr">12</xref>). For the upper
          limb, quantitative Dixon FF imaging and T2 relaxation time imaging (a surrogate of muscle
          inflammation (<xref rid="bib13" ref-type="bibr">13</xref>)) were performed and maps
          processed, modelling for the presence of fat. Regions of interest (ROIs) were defined for
          the upper and lower limb for multiple image slices and FF and T2 relaxation times were
          calculated together as area-weighted averages. CSA and cCSA were also calculated to
          quantify the area of viable muscle tissue remaining (<xref rid="bib14" ref-type="bibr">14</xref>)
          (see supplementary material). A total FF, CSA, and cCSA was also calculated for the leg
          and arm of each participant by a weighted average of all the individual muscle groups in
          that limb. Results are presented by muscle group across all participants. Six healthy male
          controls, matched by bone age at baseline (as all participants in the trial had delayed
          puberty and bone age), underwent the same MRI protocol at baseline in the original study;
          these data were used as an initial comparator in this follow-up study.</p>
      </sec>
      <sec>
        <title>Statistical analysis and approvals</title>
        <p>This was an observational study and the recruitment target reflected the number of boys
          who were enrolled in the original clinical trial. All data are presented as mean &#x000b1; <sc>
          s.d.</sc> unless stated otherwise. Baseline and &#x02018;end of regimen&#x02019; data from
          the original testosterone study has been used in the longitudinal analysis (<xref
            rid="bib3" ref-type="bibr">3</xref>). Paired<italic toggle="yes"> t</italic>-tests (or
          Wilcoxon rank-sum techniques if variables not normally distributed) were used to compare
          outcome measures during longitudinal analysis. Statistical significance was taken to be <italic
            toggle="yes">P</italic> &#x0003c; 0.05. Stata v15 was used for statistical analysis
          (Stata Statistical Software, release 14; StataCorp).</p>
        <p>The study was approved by the Newcastle upon Tyne Research Ethics Committee. Informed,
          written consent was obtained from the participants.</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <sec>
        <title>Baseline characteristics</title>
        <p>Fifteen participants completed the initial testosterone clinical study (<xref rid="bib3"
            ref-type="bibr">3</xref>). The last participant&#x02019;s final visit of the original
          study was February 2019. All participants from the original study consented to take part
          in the follow-up study. They had been on GC therapy for a mean of 13.1 years (<sc>s.d.</sc>)
          by the final visit (+5.0 years). The GC regimen remained unchanged during both the regimen
          and follow-up for all participants. Nine participants were on deflazacort (mean GC dose
          0.55 mg/kg; <sc>s.d.</sc> 0.13) and 6 on prednisolone (mean 0.47 mg/kg; <sc>s.d.</sc>
          0.13) (<xref rid="tbl1" ref-type="table">Table 1</xref>). One subject was diagnosed with
          severe anxiety during the COVID-19 pandemic and as a result felt unable to attend for the
          full study visit. He had pubertal assessment and bloods taken, the results of which have
          been included in the analysis. Three participants required aeroplane travel to attend the
          study centre and so could not have a full assessment performed due to COVID-19
          restrictions. Remote consultations were carried out for these participants, including
          pubertal assessment performed by the local doctor, but this did not include bone age
          x-ray, MRI, or functional measures. <table-wrap position="float" id="tbl1">
            <label>Table 1</label>
            <caption>
              <p>Individual patient characteristics.</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th rowspan="2" align="left" valign="bottom" colspan="1" />
                  <th align="center" valign="bottom" rowspan="1" colspan="1">Baseline age (years)</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">Baseline bone age
          (years)</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">Final age (years)</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">Final bone age (years)</th>
                  <th rowspan="2" align="left" valign="bottom" colspan="1">GC regimen</th>
                  <th rowspan="2" align="center" valign="bottom" colspan="1">GC daily dose (mg/kg)</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">Initial NSAA</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">Final NSAA</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">Initial PUL</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">Final PUL</th>
                </tr>
                <tr>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+0y</bold>
                  </th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+0y</bold>
                  </th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+5y</bold>
                  </th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+5y</bold>
                  </th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+0y</bold>
                  </th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+5y</bold>
                  </th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+0y</bold>
                  </th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+5y</bold>
                  </th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">14.8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">18.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">15</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">D daily</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.52</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">2</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">36</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">21</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">2</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">13.3</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">17.4</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">11</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">P daily</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.67</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">4</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">NA</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">26</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">17</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">4</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">14.8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">11</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">20.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">15.5</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">P daily</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.59</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">11</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">NA</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">41</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">22</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">5</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">12.4</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">12.5</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">17.6</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">16</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">D daily</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.44</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">NA</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">NA</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">34</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">35</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">6</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">14.5</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">19.6</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">15.5</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">P daily</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.33</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">NA</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">NA</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">38</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">20</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">16.3</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">11</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">21.4</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">15</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">P daily</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.48</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">NA</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">NA</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">26</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">18</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">12.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">17.2</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">
</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">D daily</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.5</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">16</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">40</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">9</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">12.3</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">17.2</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">
</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">D daily</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.49</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">30</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">42</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">42</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">16.8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">12</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">21.9</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">
</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">D daily</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.69</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">4</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">NA</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">20</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">11</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">12.8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">9.5</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">17.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">
</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">P 10 on/off</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.38</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">23</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">41</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">39</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">12</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">14.2</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">18.8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">13.5</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">D daily</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.69</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">13</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">28</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">19</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">13</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">14.8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">19.5</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">17.5</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">P daily</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.38</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">23</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">16</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">40</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">38</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">14</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">12.3</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">12.5</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">16.8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">16</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">D daily</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.3</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">1</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">NA</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">31</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">16</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">15</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">13.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">9</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">17.6</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">15</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">D daily</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.62</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">26</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">31</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">24</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">16</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">13.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">17.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">&#x02013;</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">D daily</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.69</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">35</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">ND</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>D, deflazacort; P, prednisolone; NA, non-ambulant; ND, not done; NSAA, North Star
          ambulatory assessment; PUL, performance of the upper limb; T, testosterone.</p>
              </fn>
              <fn>
                <p>Baseline (T+0y) denotes time 0 years at start of 2-year testosterone regimen.
          Final (T+5y) denotes time 5 years at end of extended follow-up, approx. 3 years after
          cessation of testosterone regimen.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </p>
      </sec>
      <sec>
        <title>Pubertal status</title>
        <p>All subjects were Tanner stage G5, P5 at the final follow-up (timepoint +5.0 years).
          Bilateral testicular volume significantly increased from 5.6 mL (<sc>s.d.</sc> 0.9) at the
          end of pubertal induction with testosterone (timepoint +2.0 years) to 13.8 mL (<sc>s.d.</sc>
          1.8) at 6 months afterwards (timepoint +2.5 years) to 21.2 mL (<sc>s.d.</sc> 3.5) at the
          final follow-up (timepoint +5.0 years) (<italic toggle="yes">P</italic> &#x0003c; 0.001
          for difference between end of regimen, +2.0 years, and final follow-up, +5.0 years). At
          the end of regimen (timepoint +2.0 years), the mean testosterone level was 10.5 nmol (<sc>
          s.d.</sc> 7.5). Testosterone levels remained similar at 6 months after the last injection
          (timepoint +2.5 years; 8.6 nmol/L <sc>s.d.</sc> 3.4) and final follow-up at 5.0 years
          (10.3 nmol/L <sc>s.d.</sc> 6.5, <italic toggle="yes">P</italic>&#x02009;=&#x02009;0.09),
          but with a wide variability from &#x0003c;1&#x02013;26.7 nmol.</p>
        <p>LH/FSH levels were suppressed at the end of the 2-year testosterone regimen (median LH
          &#x0003c; 0.1 IU/L (IQR 0.1&#x02013;0.1), median FSH &#x0003c; 0.1 IU/L (IQR
          0.1&#x02013;1.2)), but activation of the hypothalamo-pituitary axis was evident during
          follow-up, with LH and FSH levels increasing to 5.3 IU/L (IQR 3.2&#x02013;5.9) and 7.9
          IU/L (IQR 5.1&#x02013;10.4) respectively by 6 months after the last injection (timepoint
          +2.5 years). Gonadotrophins remained similar at the final follow-up; LH was 3.9 IU/L (IQR
          1.7&#x02013;6.9) and FSH 4.7 IU/L (IQR 2.2&#x02013;7.0, <italic toggle="yes">P</italic>-value
          for difference between end of regimen, timepoint +2.0 years and final follow-up, timepoint
          +5.0 years was 0.03 and 0.02, respectively).</p>
        <p>A significant increase in inhibin B levels occurred from baseline to final follow-up
          (55.6 pg/mL (<sc>s.d.</sc> 47.0) to 158.2 pg/mL (<sc>s.d.</sc> 87.6), <italic toggle="yes">
          P</italic>&#x02009;=&#x02009;0.004) but final levels were lower than the age- and
          sex-matched reference values (mean 305 pg/mL; IQR 240&#x02013;445 pg/mL) (<xref
            rid="bib15" ref-type="bibr">15</xref>).</p>
        <p>AMH levels decreased significantly from a median of 437 pmol/L (IQR 185&#x02013;640) at
          baseline to 77.7 (31.8&#x02013;934) at the final follow-up (<italic toggle="yes">P</italic>-value
          for difference&#x02009;=&#x02009;0.02), a value that is similar to the median value for
          18-year-old men reported in a population-based study (median 55.6 pmol/L) (<xref
            rid="bib16" ref-type="bibr">16</xref>).</p>
        <p>One participant (highlighted with the letter &#x02018;a&#x02019; in <xref rid="tbl2"
            ref-type="table">Table 2</xref>) had restarted testosterone supplementation during the
          final year of follow-up because his testicular volume had not increased, and his
          testosterone level remained low. He had been given one injection of 1 g testosterone
          undecanoate (Nebido) by the time of his follow-up study visit and was due an injection;
          therefore, his data were included in the analysis. <table-wrap position="float" id="tbl2">
            <label>Table 2</label>
            <caption>
              <p>Pubertal characteristics and gonadal function.</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th rowspan="2" align="left" valign="bottom" colspan="1" />
                  <th align="center" valign="bottom" rowspan="1" colspan="1">T at end of regimen
          (nmol/L)</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">T 6 months after end
          regimen (mL)</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">T at final F/U (nmol/L)</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">LH at end of regimen
          (IU/L)</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">LH 6m after end regimen
          (IU/L)</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">LH at final F/U (IU/L)</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">FSH at end of regimen
          (IU/L)</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">FSH 6 m after end
          regimen (IU/L)</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">FSH at final F/U (IU/L)</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">Testicular vol at end
          of regimen (mL)</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">Testicular vol 6 months
          after end regimen (mL)</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">Testicular vol at final
          F/U, L,R (mL)</th>
                </tr>
                <tr>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+2y</bold>
                  </th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+2.5y</bold>
                  </th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+5y</bold>
                  </th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+2y</bold>
                  </th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+2.5y</bold>
                  </th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+5y</bold>
                  </th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+2y</bold>
                  </th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+2.5y</bold>
                  </th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+5y</bold>
                  </th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+2y</bold>
                  </th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+2.5y</bold>
                  </th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">
                    <bold>T+5y</bold>
                  </th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">14.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">17.5</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">3.2</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5.9</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">1.4</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5.5</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">4.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">3 (1, 2)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">9 (4.5, 5)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">24 (12, 12)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">2</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">18.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">11.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">15.6</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">3.6</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">1.6</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">2.5</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">2.2</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5 (2, 3)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">20 (10, 10)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">30 (15, 15)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">4</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">10.3</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">9.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">26.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">4.9</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">3.2</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">8.8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">13.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">11.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6.8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6 (3, 3)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">16 (8, 8)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">16 (8, 8)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">5<sup>a</sup></td>
                  <td align="left" valign="top" rowspan="1" colspan="1">8.3</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">8.0</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">2.6</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.6</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">4</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">1.5</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6 (3, 3)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">16 (8, 8)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">12 (6, 6)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">6<sup>b</sup></td>
                  <td align="left" valign="top" rowspan="1" colspan="1">17.9</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">11.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6.2</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">13.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">3.0</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">32.9</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">18.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">8 (4, 4)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">10 (5, 5)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">20 (10, 10)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5.2</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6.8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.5</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">8.4</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5.4</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">12.6</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6 (3, 3)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">16 (8, 8)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">18 (8, 10)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">8<sup>b</sup></td>
                  <td align="left" valign="top" rowspan="1" colspan="1">20.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">9.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">&#x0003c;1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5.9</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">7.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6.5</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">1.6</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6 (3, 3)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">8 (4, 4)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">18 (6, 6)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">9</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">7.9</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">8.9</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5.3</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">4.8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">1.2</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">8.6</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">4.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">4 (2, 2)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">20 (10, 10)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">30 (15, 15)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">10<sup>b</sup></td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6.9</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">3.8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6.9</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">13.5</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">11.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">9.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">17.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5 (2, 3)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">8 (4,4)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">12 (6, 6)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">11</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6.8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">10.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">12.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5.5</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6.9</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">8.4</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6.8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6 (3, 3)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">&#x02013;</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">30 (15, 15)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">12</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">8.9</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">9.8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">10.3</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">4.2</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.9</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">2.3</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">10 (5, 5)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">10 (5, 5)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">20 (10, 10)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">13<sup>b</sup></td>
                  <td align="left" valign="top" rowspan="1" colspan="1">7.4</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">8.3</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">3.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">1.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">2.0</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">2.2</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">4 (2, 2)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">&#x02013;</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">30 (15, 15)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">14<sup>b</sup></td>
                  <td align="left" valign="top" rowspan="1" colspan="1">31.4</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">4.9</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">4.4</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5.7</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5.3</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">10.4</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">14.4</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5.5 (2.5, 3)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">&#x02013;</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">12 (6, 6)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">15</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">4</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">4.8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">8.4</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">2.9</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">3.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">7.8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">7.0</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">4 (2,2)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">15 (7, 8)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">20 (10, 10)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">16</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5.2</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">12.8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">16.1</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6.4</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5.3</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">2.8</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">7.2</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">7.9</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">3.4</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">6 (3, 3)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">12 (6, 6)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">24 (12, 12)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">Mean (<sc>s.d.</sc>)/median
          (IQR)</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">10.5 (7.5)</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">8.6 (3.4)</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">11.0 (6.1)</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.1 (0.1, 0.1)</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">5.3 (3.2, 5.9)</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">3.9 (1.7, 6.9)</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.1 (0.1, 1.2)</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">7.9 (5.1, 10.4)</td>
                  <td align="center" valign="top" rowspan="1" colspan="1">4.7 (2.2, 7.0)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">5.6 (0.9)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">13.8 (1.8)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">21.2 (3.5)</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>FSH, follicle stimulating hormone; LH, luteinising hormone; T, testosterone.</p>
              </fn>
              <fn>
                <p><sup>a</sup>started Nebido supplementation during follow-up; <sup>b</sup>recommended
          to start testosterone supplementation following final study visit.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </p>
        <p>Following assessment as part of this study, a further five participants were commenced on
          long-term testosterone supplementation, based on a clinical and biochemical assessment
          that included suboptimal testosterone values (&#x0003c;8 nmol/L) and a decreasing
          testosterone level. These are highlighted in <xref rid="tbl2" ref-type="table">Table 2</xref>
          with the letter &#x02018;b&#x02019;.</p>
      </sec>
      <sec>
        <title>Muscle function</title>
        <p>At the time of the last testosterone injection, 7/15 participants were still ambulant, by
          final visit (3 years later) only 4/15 remained ambulant (<xref rid="tbl1" ref-type="table">Table
          1</xref>). The PUL score did not significantly change from 28.6 (<sc>s.d.</sc> 8.0) at the
          end of regimen to 25.9 (9.7) at the final follow-up (<italic toggle="yes">P</italic>&#x02009;=&#x02009;0.5),
          in contrast to natural history data in DMD which shows that PUL 2.0 is sensitive to detect
          the typical deterioration seen in the decline phase over a 2-year period (<xref
            rid="bib17" ref-type="bibr">17</xref>).</p>
      </sec>
      <sec>
        <title>Anthropometric variables</title>
        <p>Height <italic toggle="yes">Z</italic>-scores remained similar throughout, &#x02212;3.2 (<sc>
          s.d.</sc> 1.3) at baseline, &#x02212;3.4 (<sc>s.d.</sc> 1.1) at the end of regimen at
          timepoint +2.0 years and &#x02212;3.2 (<sc>s.d.</sc>1.0) at the final follow-up. The mean
          height gain was 16.7 cm (<sc>s.d.</sc> 9.9) during the overall 5-year period, giving a
          mean final height of 151.4 cm (<sc>s.d.</sc> 9.1). BMI <italic toggle="yes">Z</italic>-score
          was 1.6 (<sc>s.d.</sc> 1.4) at the end of the testosterone regimen and significantly lower
          at 1.5 (<sc>s.d.</sc> 1.4) by final follow-up (<italic toggle="yes">P</italic>-value for
          difference between baseline and final follow-up&#x02009;=&#x02009;0.04). Fat and lean mass
          indices remained similar during the course of the studies (<xref rid="tbl3"
            ref-type="table">Table 3</xref>). <table-wrap position="float" id="tbl3">
            <label>Table 3</label>
            <caption>
              <p>Anthropometric variables. Outcome variables at baseline, after 2-year incremental
          regimen of intramuscular testosterone and after 3 further years of follow-up.</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th rowspan="2" align="left" valign="bottom" colspan="1" />
                  <th align="center" valign="bottom" rowspan="1" colspan="1">Baseline</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">End of regimen mean (<sc>
          s.d.</sc>)</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">Final F/U</th>
                </tr>
                <tr>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">T+0y</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">T+2y</th>
                  <th align="center" valign="bottom" rowspan="1" colspan="1">T+5y</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">Height (cm)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">133.6 (10.7)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">142.4 (7.4)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">151.4 (9.1)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">Height <italic toggle="yes">
          Z</italic>-score</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">&#x02212;3.17 (1.3)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">&#x02212;3.44 (1.1)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">&#x02212;3.2 (1.0)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">Target height (cm)</td>
                  <td align="center" valign="top" colspan="3" rowspan="1">183.3 (4.6)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">Weight (kg)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">48.3 (12.4)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">52.8 (12.2)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">59.6 (15.7)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">Weight <italic toggle="yes">
          Z</italic>-score</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.19 (1.6)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">&#x02212;0.94 (1.8)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">&#x02212;1.0 (1.8)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">26.8 (4.5)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">26.3 (5.0)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">26.5 (7.8)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">BMI <italic toggle="yes">Z</italic>
          -score</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">2.16 (0.9)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">1.64 (1.35)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">1.5 (1.4)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">Lean mass index (kg/m<sup>2</sup>
          )</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">12.4 (2.3)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">12.8 (2.9)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">11.5 (2.7)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">Fat mass index (kg/m<sup>2</sup>
          )</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">13.6 (4.2)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">12.5 (4.3)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">14.1 (6.1)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">NSAA (if ambulant at both
          timepoints)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">18 (8.9)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">13 (7.23)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">8 (7.4)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">PUL</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">33.9 (6.7)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">30.9 (8.7)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">25.9 (9.7)</td>
                </tr>
                <tr>
                  <td align="left" valign="top" rowspan="1" colspan="1">LS BMAC <italic toggle="yes">
          Z</italic>-score</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.2 (2.2)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">0.4 (2.2)</td>
                  <td align="left" valign="top" rowspan="1" colspan="1">&#x02212;2.3 (1.1)</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
        </p>
      </sec>
      <sec>
        <title>Bone mineral density</title>
        <p>After 2 years of testosterone treatment (+2.0 years), LS BMC <italic toggle="yes">Z</italic>-score
          was 0.4 (<sc>s.d.</sc> 2.2, range &#x02212;2.8 to +4.0). By final follow-up (+5.0 years)
          it was significantly lower at &#x02212;2.3 (<sc>s.d.</sc> 1.0, range &#x02212;3.5 to
          &#x02212;0.4, <italic toggle="yes">P</italic> &#x0003c; 0.001). Six patients were on
          bisphosphonates at the beginning of the follow-up period (two were on 6 monthly zoledronic
          acid infusions, three on weekly risedronate, and one on weekly alendronate, who switched
          during the study from risedronate to effervescent as unable to swallow tablet. No patients
          stopped their bisphosphonates during the study follow-up.</p>
      </sec>
      <sec>
        <title>Bone age</title>
        <p>Bone age advanced in all patients during the extension study period but remained delayed
          overall. The mean bone age at the final follow-up was 15.0 years (<sc>s.d.</sc>1.7)
          compared to a chronological age of 18.7 years (<sc>s.d.</sc> 1.6).</p>
      </sec>
      <sec>
        <title>Muscle MRI</title>
        <sec>
          <title>Longitudinal analysis of fat fraction in upper and lower limbs</title>
          <p>Fat fraction (FF) was higher in every muscle group, and for total FF, when comparing
            healthy controls and participants with DMD at all assessments (<xref rid="tbl4"
              ref-type="table">Table 4</xref>). A significant increase in total FF of the arms and
            individually in the upper arm extensor group (UEG) and upper arm flexor group (UFG)
            groups occurred between the end of regimen (+2.0 years) and final follow-up (+5.0 years)
            with the largest increase seen in the UFG (11.8%, <italic toggle="yes">P</italic>-value
            for difference between +2.0 years and +5.0 years &#x022dc; 0.01) (<xref rid="tbl4"
              ref-type="table">Table 4</xref>). UEG and UFG values were also significantly greater
            at 5 years compared to baseline (<italic toggle="yes">P</italic> &#x0003c; 0.05). FF
            also significantly increased in all calf and thigh muscle groups from end of regimen to
            final follow-up with the greatest increase seen in the biceps femoris long head (13.8%
            increase, <italic toggle="yes">P</italic> &#x0003c; 0.01). In the calf, the soleus had
            the biggest percentage change in FF (10.3% increase, <italic toggle="yes">P</italic>
            &#x0003c; 0.01). <table-wrap position="float" id="tbl4">
              <label>Table 4</label>
              <caption>
                <p>Upper limb MRI.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th rowspan="2" align="left" valign="bottom" colspan="1">Muscle group</th>
                    <th rowspan="2" align="center" valign="bottom" colspan="1">Number</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">DMD baseline</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">DMD end regimen</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">DMD final F/U</th>
                    <th rowspan="2" align="center" valign="bottom" colspan="1">Control</th>
                  </tr>
                  <tr>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">T+0y</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">T+2y</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">T+5y</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">T2 (ms)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">&#x02003;FEG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">31.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">29.6</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">30.4</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">28.3<sup>c</sup></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">&#x02003;UEG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">32.8</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">31.4</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">32.5<sup>a</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">29.5<sup>c</sup></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">&#x02003;FFG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">31.6</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">29.7</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">31.1<sup>a</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">28.5<sup>c</sup></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">&#x02003;UFG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">30.7</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">30.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">30.9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">29.1<sup>b</sup></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">FF (%)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">&#x02003;FEG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">11.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">10.5</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">12.4</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">3.9<sup>b</sup></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">&#x02003;UEG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">18.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">19.9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">28.5<sup>c,d</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">3.4<sup>c</sup></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">&#x02003;FFG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">12.9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">12.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">14.7</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">3.7<sup>b</sup></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">&#x02003;UFG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">20.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">26.9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">38.7<sup>c,d</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">3.6<sup>c</sup></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Total</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">13.6</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">17.0</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">23.5<sup>b</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">3.6<sup>c</sup></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">CSA (mm<sup>2</sup>)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">&#x02003;FEG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">399.6</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">513.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">417.0</td>
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">&#x02003;UEG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">874.4</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">975.6</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">914.4</td>
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">&#x02003;FFG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">883.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">925.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">952.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">&#x02003;UFG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">592.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">668.4</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">635.4</td>
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Total</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">2581.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">3082.5</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">2919.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">cCSA (mm<sup>2</sup>)</td>
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">&#x02003;FEG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">357.8</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">462.7</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">363.9<sup>b</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">&#x02003;UEG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">749.4</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">819.6</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">678.8<sup>c</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">&#x02003;FFG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">797.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">826.0</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">820.7</td>
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">&#x02003;UFG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">10</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">499.9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">513.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">396.9<sup>b,d</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Total</td>
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                    <td align="left" valign="top" rowspan="1" colspan="1">2253.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">2621.7</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">2260.4<sup>b</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1" />
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="fn2">
                  <p><italic toggle="yes">P</italic>-values with letters &#x02018;a&#x02019;,
            &#x02018;b&#x02019;, &#x02018;c&#x02019;, and &#x02018;d&#x02019; in DMD 5 years are
            paired<italic toggle="yes"> t</italic>-tests vs 2 years; <italic toggle="yes">P-</italic>values
            with letter &#x02018;e&#x02019; in DMD 5 years are paired <italic toggle="yes">t</italic>-tests
            vs baseline; <italic toggle="yes">P</italic>-values in the Control column are unpaired<italic
                      toggle="yes"> t</italic>-tests vs DMD 5 years.</p>
                </fn>
                <fn>
                  <p><sup>a</sup><italic toggle="yes">P</italic> &#x0003c; 0.06; <sup>b</sup><italic
                      toggle="yes">P</italic> &#x0003c; 0.05; <sup>c</sup><italic toggle="yes">P</italic>
            &#x0003c; 0.01; <sup>d</sup><italic toggle="yes">P</italic> &#x0003c; 0.05.</p>
                </fn>
                <fn>
                  <p>FEG, forearm extensor group; FFC, forearm flexor group; T, testosterone; Total,
            combined muscle groups; UEG, upper arm extensor group; UFG, upper arm flexor group.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </p>
          <p>When comparing the baseline and 5-year data, an increase in total FF occurred in the
            leg (31.9&#x02013;43.3%, <italic toggle="yes">P</italic> &#x0003c; 0.05) and
            individually in 4 out of 5 thigh muscle groups (rectus femoris, vastus lateralis, biceps
            femoris long head and sartorius, <xref rid="tbl5" ref-type="table">Table 5</xref>) and 2
            out of the 5 calf muscle groups (medial gastrocnemius, soleus). The FF evolution for
            individual subjects can be seen in <xref rid="fig2" ref-type="fig">Fig. 2A</xref> (for
            arm) and <xref rid="fig2" ref-type="fig">Fig. 2C</xref> (for leg). <fig position="float"
              fig-type="figure" id="fig1">
              <label>Figure 1</label>
              <caption>
                <p>Gonadal function during pubertal induction and follow-up. (A) Testosterone (T)
            levels during initial study and extension. (B) Gonadotrophin levels during initial study
            and extension (LH, luteinising hormone; FSH, follicle-stimulating hormone). (C)
            Testicular volumes during initial study and extension (TV, testicular volume). (D)
            Inhibin B levels during initial study and extension.</p>
              </caption>
              <graphic xlink:href="EC-23-0245fig1" position="float" />
            </fig>
<fig
              position="float" fig-type="figure" id="fig2">
              <label>Figure 2</label>
              <caption>
                <p>A) Arm total fat fraction and B) total cCSA measured by MRI shown for individual
            participants at baseline, end of regimen, and the final follow-up. C) Leg total fat
            fraction and D) total cCSA measured by MRI shown for individual participants at
            baseline, end of regimen, and the final follow-up.</p>
              </caption>
              <graphic xlink:href="EC-23-0245fig2" position="float" />
            </fig>
<table-wrap
              position="float" id="tbl5">
              <label>Table 5</label>
              <caption>
                <p>Lower limb MRI.</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th rowspan="3" align="left" valign="bottom" colspan="1" />
                    <th rowspan="3" align="center" valign="bottom" colspan="1">Control</th>
                    <th align="center" valign="bottom" colspan="3" rowspan="1">FF (%) <italic
                        toggle="yes">n</italic>&#x02009;=&#x02009;10</th>
                    <th align="center" valign="bottom" colspan="3" rowspan="1">CSA (mm<sup>2</sup>) <italic
                        toggle="yes">n</italic>&#x02009;=&#x02009;10</th>
                    <th align="center" valign="bottom" colspan="3" rowspan="1">cCSA (mm<sup>2</sup>) <italic
                        toggle="yes">n</italic>&#x02009;=&#x02009;10</th>
                  </tr>
                  <tr>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">BL</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">End regimen</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">Final F/U</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">BL</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">End regimen</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">Final F/U</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">BL</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">End regimen</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">Final F/U</th>
                  </tr>
                  <tr>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">T+0y</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">T+2y</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">T+5y</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">T+0y</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">T+2y</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">T+5y</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">T+0y</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">T+2y</th>
                    <th align="center" valign="bottom" rowspan="1" colspan="1">T+5y</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">TA</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">2.0<sup>a</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">11.6</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">11.0</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">17.4<sup>a</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">313.7</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">414.5</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">304.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">281.0</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">374.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">255.0<sup>a</sup></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">MG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">2.8<sup>b</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">22.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">20.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">29.7<sup>a,d</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1297.7</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1493.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1143.4<sup>b</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1024.5</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1214.9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">827.8<sup>b,d</sup></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">LG</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">2.5<sup>b</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">25.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">24.0</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">34.1<sup>a</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">561.0</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">676.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">540.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">391.5</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">485.8</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">348.8<sup>b,d</sup></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">SOL</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">2.4<sup>b</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">17.9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">18.4</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">28.7<sup>b,d</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1595.7</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1662.9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1633.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1306.9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1372.4</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1170.6<sup>a</sup></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">RF</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1.6<sup>c</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">47.5</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">48.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">60.0<sup>b,d</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">568.6</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">647.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">654.6<sup>a</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">286.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">314.4</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">243.0<sup>a</sup></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">VL</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">2.0<sup>c</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">48.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">51.4</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">60.4<sup>a,d</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1069.0</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1171.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">1056.8<sup>b</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">542.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">562.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">407.6<sup>b,d</sup></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">BFLH</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">2.7<sup>c</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">54.9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">58.0</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">71.8<sup>b,d</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">857.7</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">908.5</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">872.7<sup>c</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">355.5</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">390.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">259.3<sup>c,d</sup></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">ST</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">2.7<sup>b</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">28.2</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">32.0</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">45.3<sup>b</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">554.7</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">678.0</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">601.8<sup>b</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">410.9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">476.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">353.7<sup>b</sup></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">SART</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">5.1<sup>b</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">27.8</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">31.6</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">44.2<sup>a,d</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">235.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">271.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">253.0<sup>b</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">173.3</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">191.5</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">157.2<sup>b</sup></td>
                  </tr>
                  <tr>
                    <td align="left" valign="top" rowspan="1" colspan="1">Total</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">2.4</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">31.9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">32.5</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">43.3<sup>a,d</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">7052.1</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">7921.9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">7059.2<sup>a</sup></td>
                    <td align="left" valign="top" rowspan="1" colspan="1">4771.9</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">5381.8</td>
                    <td align="left" valign="top" rowspan="1" colspan="1">4023.2<sup>c</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="fn6">
                  <p><italic toggle="yes">P</italic>-values with letters &#x02018;a&#x02019;,
            &#x02018;b&#x02019;, and &#x02018;c&#x02019; in DMD 5 years (T+5y) are paired<italic
                      toggle="yes"> t</italic>-tests vs end of regimen (T+2y);</p>
                </fn>
                <fn id="fn7">
                  <p><italic toggle="yes">P</italic>-values with letter &#x02018;d&#x02019; in DMD 5
            years (T+5y) are paired <italic toggle="yes">t</italic>-tests vs baseline (T+0y);</p>
                </fn>
                <fn id="fn8">
                  <p><italic toggle="yes">P</italic>-values in the Control column are unpaired <italic
                      toggle="yes">t</italic>-tests vs DMD 5 years.</p>
                </fn>
                <fn>
                  <p><sup>a</sup><italic toggle="yes">P</italic> &#x0003c; 0.05; <sup>b</sup><italic
                      toggle="yes">P</italic> &#x0003c; 0.01; <sup>c</sup><italic toggle="yes">P</italic>
            &#x0003c; 0.001; <sup>d</sup><italic toggle="yes">P</italic> &#x0003c; 0.05.</p>
                </fn>
                <fn>
                  <p>BFLH, biceps femoris long head; LG, lateral gastrocnemius; MG, medial
            gastrocnemius; RF, rectus femoris (thigh); SART, sartorius; SOL, soleus; ST,
            semitendinosus; T, testosterone; TA, tibialis anterior (calf); Total, combined muscle
            groups; VL, vastus lateralis.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </p>
        </sec>
        <sec>
          <title>Longitudinal analysis of cross-sectional area in upper and lower limbs</title>
          <p>Between the end of regimen and the final follow-up, there was no change in CSA for any
            of the arm muscle groups, or for the total CSA of the arm. CSA in the calf muscle groups
            remained stable, with a significant change between end of regimen and final follow-up
            only seen in medial gastrocnemius (349.8 mm&#x000b2; decrease, <italic toggle="yes">P</italic>
            &#x0003c; 0.01), whilst significant decreases in CSA were noted from end of regimen to
            final follow-up in all thigh muscle groups, except for RF where a small increase was
            noted (<xref rid="tbl5" ref-type="table">Table 5</xref>). The total leg CSA
            significantly decreased between end of regimen and final follow-up (<italic toggle="yes">
            P</italic> &#x0003c; 0.05).</p>
        </sec>
        <sec>
          <title>Longitudinal analysis of contractile cross-sectional area in upper and lower limbs</title>
          <p>There was a significant decrease in total cCSA of the arm between end of regimen and
            final follow-up (361.3 mm&#x000b2;, <italic toggle="yes">P</italic> &#x0003c; 0.05) and
            also separately in the forearm extensor group (FEG), UEG and UFG muscle groups; with the
            largest decrease observed in UEG (140.8 mm&#x000b2;, <italic toggle="yes">P</italic>
            &#x0003c; 0.01). There was a significant decrease in cCSA in UFG from baseline to final
            follow-up (<italic toggle="yes">P</italic> &#x0003c; 0.05). In the other arm muscle
            groups, the final follow-up cCSA values were similar to baseline.</p>
          <p>A significant reduction in cCSA was also seen in all individual leg muscle groups of
            both the thigh and calf (<xref rid="tbl5" ref-type="table">Table 5</xref>) contributing
            to a decrease in total cCSA between end of regimen and final follow-up of 1358.6 mm<sup>
            2</sup> or 25.2 % (<italic toggle="yes">P</italic> &#x0003c; 0.001, <xref rid="tbl5"
              ref-type="table">Table 5</xref>). Despite the significant increase that we observed
            between baseline and end of regimen in total cCSA for the leg (<xref rid="bib3"
              ref-type="bibr">3</xref>), the final cCSA in lateral and medial gastrocnemius (calf)
            and vastus lateralis and biceps femoris long head (thigh) groups were significantly less
            than at baseline (<italic toggle="yes">P</italic> &#x0003c; 0.05 for difference between
            baseline and final follow-up). The evolution of cCSA for individual subjects can be seen
            in <xref rid="fig2" ref-type="fig">Fig. 2B</xref> (for arm) and <xref rid="fig2"
              ref-type="fig">Fig. 2D</xref> (for leg).</p>
        </sec>
      </sec>
      <sec>
        <title>T2 relaxation time</title>
        <p>T2 relaxation time data was only collected for arm muscle groups due to time constraints
          and to ensure patient comfort within the MRI scanner. There was a trend for increase in T2
          relaxation time for UEG and FFG from the end of regimen visit to final follow-up (<italic
            toggle="yes">P</italic> &#x0003c; 0.052 and <italic toggle="yes">P</italic> &#x0003c;
          0.056, indicated in <xref rid="tbl4" ref-type="table">Table 4</xref> as <italic
            toggle="yes">P</italic> &#x0003c; 0.06).</p>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>The newly revised standards of care highlight the importance of the timely recognition and
        management of pubertal delay in DMD (<xref rid="bib18" ref-type="bibr">18</xref>). This
        study describes HPG activity in adolescents with DMD following the same 2-year pubertal
        induction regimen using incremental monthly injections of intramuscular testosterone. Rather
        than ongoing relative HPG axis inactivity, the testosterone given during the 2-year pubertal
        induction regimen appeared to promote gonadotrophin release in most participants, despite
        ongoing GC use. As such, GC does not appear to suppress gonadotrophin production to the
        extent that it does before puberty. There was ongoing HPG axis activity following
        testosterone therapy, but the clinical and biochemical parameters were relatively low when
        compared to age-related norms.</p>
      <p>By the time of the final follow-up, when the mean age of participants was 18.6 years, one
        participant had already restarted testosterone supplementation and a further five were
        advised to restart after their final assessment (subjects marked &#x02018;b&#x02019; in <xref
          rid="tbl2" ref-type="table">Table 2</xref>). They all had an increase in testosterone
        levels during follow-up but they had been deemed not to be sufficient (&#x0003c;8 nmol/L).
        Therefore, just under half of the study cohort required supplementation by 3 years after
        stopping their incremental regimen. The mean testosterone level at +5.0 years was 10.3
        nmol/L, within the lower range of normal for a healthy adult male, but considerably lower
        than age-related normative mean levels of 15.4 nmol/L (<xref rid="bib18" ref-type="bibr">18</xref>).
        There was also considerable variability with the values ranging from &#x0003c;1nmol/L to
        26.7 nmol, which does not appear to be mutation specific or related to ambulation status,
        suggesting that there may be additional factors affecting the HPG axis including
        inter-individual sensitivity to GC. This highlights the need for ongoing surveillance after
        pubertal induction and for studies of larger cohorts to better understand the variability
        between individual responses.</p>
      <p>The testicular volume of 10.6 mL at the final follow-up was significantly greater than at
        all other time points during the incremental testosterone regimen but remained considerably
        lower than mean reference bilateral values for the adult testis of 31 mL (<xref rid="bib19"
          ref-type="bibr">19</xref>). Semen volume, sperm density, total sperm count, total motile
        sperm count, and serum FSH, LH, and testosterone levels have all been shown to correlate
        with testicular volume (<xref rid="bib20" ref-type="bibr">20</xref>), although numbers in
        this study are too small to demonstrate such a correlation and no semen analysis was
        undertaken. Inhibin B is secreted from the Sertoli cells in the testis. Inhibin B levels
        significantly increased from baseline to 158.2 pg/mL (<sc>s.d.</sc> 87.6), but final levels
        remained lower than age- and sex-matched reference values of 305 pg/mL (IQR 240&#x02013;445
        pg/mL) (<xref rid="bib15" ref-type="bibr">15</xref>). There was a significant positive
        correlation between testicular volume and inhibin B level at the final follow-up (T+5y), <italic
          toggle="yes">r</italic>
<sup>2</sup>&#x02009;=&#x02009;0.6. Inhibin B, FSH levels and
        testicular volumes have been shown to positively correlate with spermatogenesis and sperm
        density and the increase seen in both testicular volume and inhibin B during pubertal
        induction in this cohort of men with DMD is promising with respect to the prospect of future
        fertility, although semen analysis would be required to confirm sperm production. A
        proportion of participants also showed borderline elevation in FSH levels at the final
        follow-up (median 4.7 IU/L, IGR range 2.2&#x02013;7.0) which may reflect feedback from the
        testis to pituitary gland and be consistent with sub-optimal spermatogenesis (<xref
          rid="bib21" ref-type="bibr">21</xref>). Three of the 15 participants had FSH levels
        greater than 10.4 IU which have been shown to predict azoospermia in patients receiving
        gonadotoxic therapies (<xref rid="bib22" ref-type="bibr">22</xref>).</p>
      <p>As the results of this study and individual case reports (<xref rid="bib23" ref-type="bibr">
        23</xref>, <xref rid="bib24" ref-type="bibr">24</xref>) suggest that spermatogenesis can be
        preserved in men with DMD following pubertal induction despite long-term, high-dose GC use,
        it would be important to consider whether a young man with DMD wishes to have children in
        the future before restarting long-term testosterone supplementation as this could have an
        impact on their fertility prospects. It may be that testosterone supplementation is
        appropriate until fertility is being considered and then the use of human chorionic
        gonadotrophin may be preferred; a technique which is utilised in the treatment of
        hypogonadotrophic hypogonadism (<xref rid="bib25" ref-type="bibr">25</xref>).</p>
      <p>The extended nature of this study has highlighted the inevitable decline in muscle function
        and reduction in lumbar spine bone density that is consistent with the
        late-ambulant/non-ambulant transition phase in DMD and has been shown in other studies (<xref
          rid="bib26" ref-type="bibr">26</xref>) Given the known additional advantages of
        testosterone on bone health (<xref rid="bib27" ref-type="bibr">27</xref>), muscle and
        well-being, it will be important to continue monitoring testosterone levels in this
        population and supplement as required if levels become sub-optimal. The British Society for
        Sexual Medicine guidelines suggest that a testosterone level &#x0003c;8 nmol/L should be
        treated, although it also depends on the clinical situation (<xref rid="bib28"
          ref-type="bibr">28</xref>). Once treated it is recommended that a target testosterone
        level should be 15&#x02013;30 nmol/L. Whilst this is guidance for the healthy population,
        there are clear advantages for men with DMD to have an optimal testosterone level, as our
        previous study shows (<xref rid="bib3" ref-type="bibr">3</xref>).</p>
      <p>Our previous publication identified significant increases in both CSA and cCSA of the total
        arm and leg muscle groups during the interventional study period (and some individual muscle
        groups), from baseline to end of regimen (+2 years), suggesting the development of new
        healthy muscle tissue, whilst FF remained stable in the arms and legs (<xref rid="bib3"
          ref-type="bibr">3</xref>). In this current study, MRI data demonstrated a clear
        deterioration in muscle integrity after cessation of the testosterone treatment with
        increases in FF and either unchanged or reduced CSA leading to overall reductions in cCSA.
        Total cCSA, representing the residual functional muscle volume, increased during
        testosterone treatment (<xref rid="bib3" ref-type="bibr">3</xref>) but decreased during the
        extended follow-up period after the end of the regimen. The MRI findings in this study
        highlight the importance of prompt intervention with testosterone to treat pubertal delay in
        DMD. The initial study findings described an unexpected increase in cCSA for arms and legs
        coupled with a reduction in T2 relaxation time for the arm, and no increases in total limb
        FF, which suggested that testosterone treatment improved muscle strength and perhaps also
        ameliorated the underlying inflammatory process in DMD. These findings were in contrast to
        several natural history MRI studies of DMD that show disease progression with time and an
        increase in FF with time in adolescents with DMD (<xref rid="bib14" ref-type="bibr">14</xref>
        , <xref rid="bib29" ref-type="bibr">29</xref>, <xref rid="bib30" ref-type="bibr">30</xref>).
        It remains unclear whether exogenous testosterone confers an additional benefit in terms of
        contractile muscle bulk and inflammatory status of muscle in DMD or whether the 2-year
        incremental regimen was offered early enough to temporarily halt the later muscle decline.
        We propose to carry out further work in this area.</p>
      <sec>
        <title>Limitations of the study</title>
        <p>Unfortunately, the COVID-19 pandemic had a considerable impact on data collection in this
          study and so the number of study visits was reduced from two to one. Despite this, all
          patients agreed to take part and data were collected consistently. The original cohort
          only contained 15 participants and therefore the size of the follow-up cohort was limited.
          The cohort is too small, in particular, to draw strong conclusions regarding the
          trajectory of the bone density data in relation to testosterone use. It is difficult to
          obtain accurate measures of height, as contractures and then loss of ambulation make
          standing height impossible, whilst ulnar length can overestimate height. This may have had
          an impact on the final DEXA <italic toggle="yes">Z</italic>-scores. In order to avoid
          this, both standing height and ulnar length/arm span were recorded in patients during the
          decline phase, so that consistent measurement techniques could be maintained.</p>
      </sec>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>Earlier testosterone therapy is associated with ongoing HPG activity. The increase in
        inhibin B observed in this cohort of men with DMD is promising with respect to future
        fertility. Testosterone levels and testicular volumes, however, remain lower than adult
        reference values. Upper and lower limb muscle functional volume increased during the
        intervention but declined in the years after cessation of supplementation. Given the known
        additional advantages of testosterone on bone health, muscle, and well-being and the
        likelihood for a further reduction in HPG function associated with the inevitable health
        deterioration seen in young adults with DMD, a more proactive approach to ongoing
        testosterone supplementation may be appropriate following pubertal induction.</p>
    </sec>
    <sec sec-type="COI-statement">
      <title>Declaration of interest</title>
      <p>Volker Straub is or has been on advisory boards for Astellas Gene Therapies, Biogen,
        Edgewise Therapeutics, Kate Therapeutics, ML Bio Solutions, Novartis Gene Therapies, Roche,
        Sanofi, Sarepta Therapeutics, Vertex Pharmaceuticals, and Wave Therapeutics. He received
        speaker honoraria from Pfizer, Sanofi, and Sarepta Therapeutics. He has research
        collaborations with Sarepta Therapeutics and Sanofi. Robert Muni Lofra has received speaker
        honoraria from Biogen and has been recently on advisory boards for Roche and Biogen. Anna
        Mayhew has served on medical/scientific advisory boards for Regenxbio, Sarepta, Biogen, and
        Roche and has received fees for consulting and training services from Biogen, Roche,
        Novartis, Biohaven, PTC, Sarepta, Italfarmaco, Dyne, Pfizer, Summit, Catabasis, Santhera,
        Vision, Lysogene, Modis, Amicus, Analysis Group, MDUK, and DUK. Michela Guglieri has
        received speaker honoraria from Sarepta, Novartis, and Italfarmaco and is or has been on
        advisory boards for PTC Therapeutics, Pfizer, NS Pharma, and Dyne. She has research
        collaborations with Sarepta and PTC Therapeutics. Kieren Hollingsworth performs commercial
        work with Astellas Gene Therapies. Claire Wood, Edeina Bokaie, Eric Hughes, Joseph Mcelvery,
        Rod Mitchell, and Tim Cheetham have no conflicts of interest.</p>
    </sec>
    <sec>
      <title>Funding</title>
      <p>The study was generously funded by Duchenne UK. CW was funded by the <funding-source>
          <institution-wrap>
            <institution>Medical Research Council</institution>
            <institution-id institution-id-type="doi">
              http://dx.doi.org/10.13039/501100000265</institution-id>
          </institution-wrap>
        </funding-source>/MDUK
        (MR/N020588/1). RTM is funded by a <funding-source>
          <institution-wrap>
            <institution>UK Research and Innovation</institution>
            <institution-id institution-id-type="doi">
              http://dx.doi.org/10.13039/100014013</institution-id>
          </institution-wrap>
        </funding-source>
        (UKRI) Future Leaders Fellowship MR/S017151/1.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>We offer thanks to the participants and their families for providing their time to take
        part in this study; Meredith James, Dionne Moat, Jas Sodhi, and the nursing staff in the CRF
        for their help in collecting data; and Tim Hodgson, Dot Wallace, and Louise Ward, senior
        research radiographers at the Newcastle Magnetic Resonance Centre, for acquiring the MRI
        data.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Duan</surname>
              <given-names>D</given-names>
            </name><name>
              <surname>Goemans</surname>
              <given-names>N</given-names>
            </name><name>
              <surname>Takeda</surname>
              <given-names>S</given-names>
            </name><name>
              <surname>Mercuri</surname>
              <given-names>E</given-names>
            </name> &#x00026; <name>
              <surname>Aartsma-Rus</surname>
              <given-names>A</given-names>
            </name></person-group>. <article-title>Duchenne
          muscular dystrophy</article-title>. <source>Nature Reviews. Disease Primers</source><year>
          2021</year><volume>7</volume><fpage>13</fpage>. (<pub-id pub-id-type="doi">
          10.1038/s41572-021-00248-3</pub-id>)</mixed-citation>
      </ref>
      <ref id="bib2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Matthews</surname>
              <given-names>E</given-names>
            </name><name>
              <surname>Brassington</surname>
              <given-names>R</given-names>
            </name><name>
              <surname>Kuntzer</surname>
              <given-names>T</given-names>
            </name><name>
              <surname>Jichi</surname>
              <given-names>F</given-names>
            </name> &#x00026; <name>
              <surname>Manzur</surname>
              <given-names>AY</given-names>
            </name></person-group>. <article-title>Corticosteroids
          for the treatment of Duchenne muscular dystrophy</article-title>. <source>Cochrane
          Database of Systematic Reviews</source><year>2016</year><fpage>5 CD003725</fpage>. (<pub-id
            pub-id-type="doi">10.1002/14651858.CD003725.pub4</pub-id>)</mixed-citation>
      </ref>
      <ref id="bib3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Wood</surname>
              <given-names>CL</given-names>
            </name><name>
              <surname>Hollingsworth</surname>
              <given-names>KG</given-names>
            </name><name>
              <surname>Hughes</surname>
              <given-names>E</given-names>
            </name><name>
              <surname>Punniyakodi</surname>
              <given-names>S</given-names>
            </name><name>
              <surname>Muni-Lofra</surname>
              <given-names>R</given-names>
            </name><name>
              <surname>Mayhew</surname>
              <given-names>A</given-names>
            </name><name>
              <surname>Mitchell</surname>
              <given-names>RT</given-names>
            </name><name>
              <surname>Guglieri</surname>
              <given-names>M</given-names>
            </name><name>
              <surname>Cheetham</surname>
              <given-names>TD</given-names>
            </name> &#x00026; <name>
              <surname>Straub</surname>
              <given-names>V</given-names>
            </name></person-group>. <article-title>Pubertal
          induction in adolescents with DMD is associated with high satisfaction, gonadotropin
          release and increased muscle contractile surface area</article-title>. <source>European
          Journal of Endocrinology</source><year>2021</year><volume>184</volume><fpage>67</fpage>
          &#x02013;<lpage>79</lpage>. (<pub-id pub-id-type="doi">10.1530/EJE-20-0709</pub-id>)<pub-id
            pub-id-type="pmid">33112266</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author">
            <name>
              <surname>Birnkrant</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Bushby</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bann</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Apkon</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Blackwell</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brumbaugh</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Case</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Clemens</surname>
              <given-names>PR</given-names>
            </name>
            <name>
              <surname>Hadjiyannakis</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pandya</surname>
              <given-names>S</given-names>
            </name>
          </person-group>, <bold>
            <italic toggle="yes">et al</italic>
          </bold>. <article-title>Diagnosis and
          management of Duchenne muscular dystrophy, Part 1: diagnosis, and neuromuscular,
          rehabilitation, endocrine, and gastrointestinal and nutritional management</article-title>
          . <source>Lancet. Neurology</source><year>2018</year><volume>17</volume><fpage>251</fpage>
          &#x02013;<lpage>267</lpage>. (<pub-id pub-id-type="doi">10.1016/S1474-4422(1830024-3</pub-id>
          )<pub-id pub-id-type="pmid">29395989</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Wood</surname>
              <given-names>CL</given-names>
            </name><name>
              <surname>Cheetham</surname>
              <given-names>TD</given-names>
            </name><name>
              <surname>Hollingsworth</surname>
              <given-names>KG</given-names>
            </name><name>
              <surname>Guglieri</surname>
              <given-names>M</given-names>
            </name><name>
              <surname>Ailins-Sahun</surname>
              <given-names>Y</given-names>
            </name><name>
              <surname>Punniyakodi</surname>
              <given-names>S</given-names>
            </name><name>
              <surname>Mayhew</surname>
              <given-names>A</given-names>
            </name> &#x00026; <name>
              <surname>Straub</surname>
              <given-names>V</given-names>
            </name></person-group>. <article-title>Observational
          study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne
          muscular dystrophy</article-title>. <source>BMC Pediatrics</source><year>2019</year><volume>
          19</volume><fpage>131</fpage>. (<pub-id pub-id-type="doi">10.1186/s12887-019-1503-x</pub-id>
          )<pub-id pub-id-type="pmid">31023296</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Marshall</surname>
              <given-names>WA</given-names>
            </name> &#x00026; <name>
              <surname>Tanner</surname>
              <given-names>JM</given-names>
            </name></person-group>. <article-title>Variations
          in the pattern of pubertal changes in boys</article-title>. <source>Archives of Disease in
          Childhood</source><year>1970</year><volume>45</volume><fpage>13</fpage>&#x02013;<lpage>23</lpage>.
          (<pub-id pub-id-type="doi">10.1136/adc.45.239.13</pub-id>)<pub-id pub-id-type="pmid">
          5440182</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib7">
        <label>7</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name>
              <surname>Greulich</surname>
              <given-names>WW</given-names>
            </name> &#x00026; <name>
              <surname>Pyle</surname>
              <given-names>SI</given-names>
            </name></person-group><source>Radiographic
          Atlas of Skeletal Development of the Hand and Wrist</source>, <edition>2nd ed.</edition>
          Stanford: <publisher-name>Stanford University Press</publisher-name><year>1959</year>.</mixed-citation>
      </ref>
      <ref id="bib8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author">
            <name>
              <surname>Mayhew</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Coratti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mazzone</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Klingels</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>James</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pane</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Straub</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Goemans</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mercuri</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ricotti</surname>
              <given-names>V</given-names>
            </name>
          </person-group>, <bold>
            <italic toggle="yes">et al</italic>
          </bold>. <article-title>Performance of
          Upper Limb module for Duchenne muscular dystrophy</article-title>. <source>Developmental
          Medicine and Child Neurology</source><year>2019</year><volume> 62</volume><fpage>633</fpage>
          &#x02013;<lpage>639</lpage>. (<pub-id pub-id-type="doi">10.1111/dmcn.14361</pub-id>)<pub-id
            pub-id-type="pmid">31538331</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author">
            <name>
              <surname>Mayhew</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Cano</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Scott</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Eagle</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bushby</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Manzur</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Muntoni</surname>
              <given-names>F</given-names>
            </name>
          </person-group> &#x00026; <collab>North
          Star Clinical Network for Neuromuscular Disease</collab>. <article-title>Detecting
          meaningful change using the North Star Ambulatory Assessment in Duchenne muscular
          dystrophy</article-title>. <source>Developmental Medicine and Child Neurology</source><year>
          2013</year><volume>55</volume><fpage>1046</fpage>&#x02013;<lpage>1052</lpage>. (<pub-id
            pub-id-type="doi">10.1111/dmcn.12220</pub-id>)<pub-id pub-id-type="pmid">23909763</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Crabtree</surname>
              <given-names>NJ</given-names>
            </name><name>
              <surname>Kibirige</surname>
              <given-names>MS</given-names>
            </name><name>
              <surname>Fordham</surname>
              <given-names>JN</given-names>
            </name><name>
              <surname>Banks</surname>
              <given-names>LM</given-names>
            </name><name>
              <surname>Muntoni</surname>
              <given-names>F</given-names>
            </name><name>
              <surname>Chinn</surname>
              <given-names>D</given-names>
            </name><name>
              <surname>Boivin</surname>
              <given-names>CM</given-names>
            </name> &#x00026; <name>
              <surname>Shaw</surname>
              <given-names>NJ</given-names>
            </name></person-group>. <article-title>The
          relationship between lean body mass and bone mineral content in paediatric health and
          disease</article-title>. <source>Bone</source><year>2004</year><volume>35</volume><fpage>
          965</fpage>&#x02013;<lpage>972</lpage>. (<pub-id pub-id-type="doi">
          10.1016/j.bone.2004.06.009</pub-id>)<pub-id pub-id-type="pmid">15454104</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Hollingsworth</surname>
              <given-names>KG</given-names>
            </name><name>
              <surname>Higgins</surname>
              <given-names>DM</given-names>
            </name><name>
              <surname>McCallum</surname>
              <given-names>M</given-names>
            </name><name>
              <surname>Ward</surname>
              <given-names>L</given-names>
            </name><name>
              <surname>Coombs</surname>
              <given-names>A</given-names>
            </name> &#x00026; <name>
              <surname>Straub</surname>
              <given-names>V</given-names>
            </name></person-group>. <article-title>Investigating
          the quantitative fidelity of prospectively undersampled chemical shift imaging in muscular
          dystrophy with compressed sensing and parallel imaging reconstruction</article-title>. <source>Magnetic
          Resonance in Medicine</source><year>2014</year><volume>72</volume><fpage>1610</fpage>
          &#x02013;<lpage>1619</lpage>. (<pub-id pub-id-type="doi">10.1002/mrm.25072</pub-id>)<pub-id
            pub-id-type="pmid">24347306</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Loughran</surname>
              <given-names>T</given-names>
            </name><name>
              <surname>Higgins</surname>
              <given-names>DM</given-names>
            </name><name>
              <surname>McCallum</surname>
              <given-names>M</given-names>
            </name><name>
              <surname>Coombs</surname>
              <given-names>A</given-names>
            </name><name>
              <surname>Straub</surname>
              <given-names>V</given-names>
            </name> &#x00026; <name>
              <surname>Hollingsworth</surname>
              <given-names>KG</given-names>
            </name></person-group>. <article-title>Improving
          highly accelerated fat fraction measurements for clinical trials in muscular dystrophy:
          origin and quantitative effect of R2* changes</article-title>. <source>Radiology</source><year>
          2015</year><volume>275</volume><fpage>570</fpage>&#x02013;<lpage>578</lpage>. (<pub-id
            pub-id-type="doi">10.1148/radiol.14141191</pub-id>)<pub-id pub-id-type="pmid">25575118</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author">
            <name>
              <surname>Carlier</surname>
              <given-names>PG</given-names>
            </name>
          </person-group>. <article-title>Global
          T2 versus water T2 in NMR imaging of fatty infiltrated muscles: different methodology,
          different information and different implications</article-title>. <source>Neuromuscular
          Disorders</source><year>2014</year><volume>24</volume><fpage>390</fpage>&#x02013;<lpage>
          392</lpage>. (<pub-id pub-id-type="doi">10.1016/j.nmd.2014.02.009</pub-id>)<pub-id
            pub-id-type="pmid">24656605</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author">
            <name>
              <surname>Ricotti</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>MRB</given-names>
            </name>
            <name>
              <surname>Sinclair</surname>
              <given-names>CDJ</given-names>
            </name>
            <name>
              <surname>Butler</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Ridout</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Hogrel</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Emira</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Morrow</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Reilly</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Hanna</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>, <bold>
            <italic toggle="yes">et al</italic>
          </bold>. <article-title>Upper limb
          evaluation in Duchenne muscular dystrophy: fat-water quantification by MRI, muscle force
          and function define endpoints for clinical trials</article-title>. <source>PLoS One</source><year>
          2016</year><volume>11</volume><fpage>e0162542</fpage>. (<pub-id pub-id-type="doi">
          10.1371/journal.pone.0162542</pub-id>)<pub-id pub-id-type="pmid">27649492</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Kelsey</surname>
              <given-names>TW</given-names>
            </name><name>
              <surname>Miles</surname>
              <given-names>A</given-names>
            </name><name>
              <surname>Mitchell</surname>
              <given-names>RT</given-names>
            </name><name>
              <surname>Anderson</surname>
              <given-names>RA</given-names>
            </name><name>
              <surname>Hamish</surname>
              <given-names>WHB</given-names>
            </name> &#x00026; <name>
              <surname>Wallace</surname>
              <given-names>B</given-names>
            </name></person-group>. <article-title>A
          normative model of serum inhibin B in young males</article-title>. <source>PLoS One</source><year>
          2016</year><volume>11</volume><fpage>e0153843</fpage>. (<pub-id pub-id-type="doi">
          10.1371/journal.pone.0153843</pub-id>)<pub-id pub-id-type="pmid">27077369</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Jopling</surname>
              <given-names>H</given-names>
            </name><name>
              <surname>Yates</surname>
              <given-names>A</given-names>
            </name><name>
              <surname>Burgoyne</surname>
              <given-names>N</given-names>
            </name><name>
              <surname>Hayden</surname>
              <given-names>K</given-names>
            </name><name>
              <surname>Chaloner</surname>
              <given-names>C</given-names>
            </name> &#x00026; <name>
              <surname>Tetlow</surname>
              <given-names>L</given-names>
            </name></person-group>. <article-title>Paediatric
          anti-M&#x000fc;llerian hormone measurement: male and female reference intervals
          established using the automated Beckman Coulter Access AMH assay</article-title>. <source>Endocrinology,
          Diabetes and Metabolism</source><year>2018</year><volume>1</volume><fpage>e00021</fpage>.
          (<pub-id pub-id-type="doi">10.1002/edm2.21</pub-id>)</mixed-citation>
      </ref>
      <ref id="bib17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author">
            <name>
              <surname>Mayhew</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Coratti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mazzone</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Klingels</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>James</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pane</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Straub</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Goemans</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mercuri</surname>
              <given-names>E</given-names>
            </name>
          </person-group> &#x00026; <collab>Pul
          Working Group</collab>. <article-title>Performance of Upper Limb module for Duchenne
          muscular dystrophy</article-title>. <source>Developmental Medicine and Child Neurology</source><year>
          2020</year><volume>62</volume><fpage>633</fpage>&#x02013;<lpage>639</lpage>. (<pub-id
            pub-id-type="doi">10.1111/dmcn.14361</pub-id>)<pub-id pub-id-type="pmid">31538331</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Kelsey</surname>
              <given-names>TW</given-names>
            </name><name>
              <surname>Li</surname>
              <given-names>LQ</given-names>
            </name><name>
              <surname>Mitchell</surname>
              <given-names>RT</given-names>
            </name><name>
              <surname>Whelan</surname>
              <given-names>A</given-names>
            </name><name>
              <surname>Anderson</surname>
              <given-names>RA</given-names>
            </name> &#x00026; <name>
              <surname>Wallace</surname>
              <given-names>WHB</given-names>
            </name></person-group>. <article-title>A
          validated age-related normative model for male total testosterone shows increasing
          variance but no decline after age 40 years</article-title>. <source>PLoS One</source><year>
          2014</year><volume>9</volume><fpage>e109346</fpage>. (<pub-id pub-id-type="doi">
          10.1371/journal.pone.0109346</pub-id>)<pub-id pub-id-type="pmid">25295520</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Rundle</surname>
              <given-names>AT</given-names>
            </name> &#x00026; <name>
              <surname>Sylvester</surname>
              <given-names>PE</given-names>
            </name></person-group>. <article-title>Measurement
          of testicular volume. Its application to assessment of maturation, and its use in
          diagnosis of hypogonadism</article-title>. <source>Archives of Disease in Childhood</source><year>
          1962</year><volume>37</volume><fpage>514</fpage>&#x02013;<lpage>517</lpage>. (<pub-id
            pub-id-type="doi">10.1136/adc.37.195.514</pub-id>)<pub-id pub-id-type="pmid">13975542</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Sakamoto</surname>
              <given-names>H</given-names>
            </name><name>
              <surname>Ogawa</surname>
              <given-names>Y</given-names>
            </name> &#x00026; <name>
              <surname>Yoshida</surname>
              <given-names>H</given-names>
            </name></person-group>. <article-title>Relationship
          between testicular volume and testicular function: comparison of the Prader orchidometric
          and ultrasonographic measurements in patients with infertility</article-title>. <source>Asian
          Journal of Andrology</source><year>2008</year><volume>10</volume><fpage>319</fpage>
          &#x02013;<lpage>324</lpage>. (<pub-id pub-id-type="doi">10.1111/j.1745-7262.2008.00340.x</pub-id>
          )<pub-id pub-id-type="pmid">18097521</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Gordetsky</surname>
              <given-names>J</given-names>
            </name><name>
              <surname>Wijngaarden Van</surname>
              <given-names>E</given-names>
            </name> &#x00026; <name>
              <surname>O&#x02019;Brien</surname>
              <given-names>J</given-names>
            </name></person-group>. <article-title>Redefining
          abnormal follicle-stimulating hormone in the male infertility population</article-title>. <source>BJU
          International</source><year>2012</year><volume>110</volume><fpage>568</fpage>&#x02013;<lpage>
          572</lpage>. (<pub-id pub-id-type="doi">10.1111/j.1464-410X.2011.10783.x</pub-id>)<pub-id
            pub-id-type="pmid">22177092</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib22">
        <label>22</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Kelsey</surname>
              <given-names>TW</given-names>
            </name><name>
              <surname>McConville</surname>
              <given-names>L</given-names>
            </name><name>
              <surname>Edgar</surname>
              <given-names>AB</given-names>
            </name><name>
              <surname>Ungurianu</surname>
              <given-names>AI</given-names>
            </name><name>
              <surname>Mitchell</surname>
              <given-names>RT</given-names>
            </name><name>
              <surname>Anderson</surname>
              <given-names>RA</given-names>
            </name> &#x00026; <name>
              <surname>Wallace</surname>
              <given-names>WHB</given-names>
            </name></person-group>. <article-title>Follicle
          stimulating hormone is an accurate predictor of azoospermia in childhood cancer survivors</article-title>
          . <source>PLoS One</source><year>2017</year><volume>12</volume><fpage>e0181377</fpage>. (<pub-id
            pub-id-type="doi">10.1371/journal.pone.0181377</pub-id>)<pub-id pub-id-type="pmid">
          28727831</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib23">
        <label>23</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author">
            <collab>Action Duchene</collab>
          </person-group>. <article-title>Mitch Coles
          &#x02013; &#x0201c;Living my life the way I want to live it</article-title>&#x0201d;.
          London, UK: Action Duchenne, <year>2019</year>. (available at: <ext-link
            xlink:href="https://www.actionduchenne.org/stories/mitch-coles-living-my-life-the-way-i-want-to-live-it/"
            ext-link-type="uri">
          https://www.actionduchenne.org/stories/mitch-coles-living-my-life-the-way-i-want-to-live-it/</ext-link>
          )</mixed-citation>
      </ref>
      <ref id="bib24">
        <label>24</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author">
            <collab>The Guardian</collab>
          </person-group>. <article-title>My lifelong
          desire</article-title>. London, UK: The Guardian, <year>2007</year>. (available at: <ext-link
            xlink:href="https://www.theguardian.com/society/2007/jan/15/health.socialcare"
            ext-link-type="uri">https://www.theguardian.com/society/2007/jan/15/health.socialcare</ext-link>
          )</mixed-citation>
      </ref>
      <ref id="bib25">
        <label>25</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Lee</surname>
              <given-names>JA</given-names>
            </name> &#x00026; <name>
              <surname>Ramasamy</surname>
              <given-names>R</given-names>
            </name></person-group>. <article-title>Indications
          for the use of human chorionic gonadotropic hormone for the management of infertility in
          hypogonadal men</article-title>. <source>Translational Andrology and Urology</source><year>
          2018</year><volume>7</volume>(<issue>Supplement 3</issue>) <fpage>S348</fpage>&#x02013;<lpage>
          S352</lpage>. (<pub-id pub-id-type="doi">10.21037/tau.2018.04.11</pub-id>)<pub-id
            pub-id-type="pmid">30159241</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib26">
        <label>26</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Crabtree</surname>
              <given-names>NJ</given-names>
            </name><name>
              <surname>Roper</surname>
              <given-names>H</given-names>
            </name> &#x00026; <name>
              <surname>Shaw</surname>
              <given-names>NJ</given-names>
            </name></person-group>. <article-title>Cessation
          of ambulation results in a dramatic loss of trabecular bone density in boys with Duchenne
          muscular dystrophy (DMD)</article-title>. <source>Bone</source><year>2022</year><volume>
          154</volume><fpage>116248</fpage>. (<pub-id pub-id-type="doi">10.1016/j.bone.2021.116248</pub-id>
          )<pub-id pub-id-type="pmid">34718220</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib27">
        <label>27</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Behre</surname>
              <given-names>HM</given-names>
            </name><name>
              <surname>Kliesch</surname>
              <given-names>S</given-names>
            </name><name>
              <surname>Leifke</surname>
              <given-names>E</given-names>
            </name><name>
              <surname>Link</surname>
              <given-names>TM</given-names>
            </name> &#x00026; <name>
              <surname>Nieschlag</surname>
              <given-names>E</given-names>
            </name></person-group>. <article-title>Long-term
          effect of testosterone therapy on bone mineral density in hypogonadal men</article-title>. <source>Journal
          of Clinical Endocrinology and Metabolism</source><year>1997</year><volume>82</volume><fpage>
          2386</fpage>&#x02013;<lpage>2390</lpage>. (<pub-id pub-id-type="doi">
          10.1210/jcem.82.8.4163</pub-id>)<pub-id pub-id-type="pmid">9253305</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib28">
        <label>28</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Hackett</surname>
              <given-names>G</given-names>
            </name><name>
              <surname>Kirby</surname>
              <given-names>M</given-names>
            </name><name>
              <surname>Edwards</surname>
              <given-names>D</given-names>
            </name><name>
              <surname>Jones</surname>
              <given-names>TH</given-names>
            </name><name>
              <surname>Wylie</surname>
              <given-names>K</given-names>
            </name><name>
              <surname>Ossei-Gerning</surname>
              <given-names>N</given-names>
            </name><name>
              <surname>David</surname>
              <given-names>J</given-names>
            </name> &#x00026; <name>
              <surname>Muneer</surname>
              <given-names>A</given-names>
            </name></person-group>. <article-title>British
          society for sexual medicine guidelines on adult testosterone deficiency, with statements
          for UK practice</article-title>. <source>Journal of Sexual Medicine</source><year>2017</year><volume>
          14</volume><fpage>1504</fpage>&#x02013;<lpage>1523</lpage>. (<pub-id pub-id-type="doi">
          10.1016/j.jsxm.2017.10.067</pub-id>)<pub-id pub-id-type="pmid">29198507</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib29">
        <label>29</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name>
              <surname>Wary</surname>
              <given-names>C</given-names>
            </name><name>
              <surname>Azzabou</surname>
              <given-names>N</given-names>
            </name><name>
              <surname>Giraudeau</surname>
              <given-names>C</given-names>
            </name><name>
              <surname>Lou&#x000eb;r Le</surname>
              <given-names>J</given-names>
            </name><name>
              <surname>Montus</surname>
              <given-names>M</given-names>
            </name><name>
              <surname>Voit</surname>
              <given-names>T</given-names>
            </name><name>
              <surname>Servais</surname>
              <given-names>L</given-names>
            </name> &#x00026; <name>
              <surname>Carlier</surname>
              <given-names>P</given-names>
            </name></person-group>. <article-title>Quantitative
          NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms
          of boys with Duchenne muscular dystrophy</article-title>. <source>NMR in Biomedicine</source><year>
          2015</year><volume>28</volume><fpage>1150</fpage>&#x02013;<lpage>1162</lpage>. (<pub-id
            pub-id-type="doi">10.1002/nbm.3352</pub-id>)<pub-id pub-id-type="pmid">26215733</pub-id>
        </mixed-citation>
      </ref>
      <ref id="bib30">
        <label>30</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author">
            <name>
              <surname>Hogrel</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Wary</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Moraux</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Azzabou</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Decostre</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Ollivier</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Canal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lilien</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ledoux</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Annoussamy</surname>
              <given-names>M</given-names>
            </name>
          </person-group>, <bold>
            <italic toggle="yes">et al</italic>
          </bold>. <article-title>Longitudinal
          functional and NMR assessment of upper limbs in Duchenne muscular dystrophy</article-title>
          . <source>Neurology</source><year>2016</year><volume>86</volume><fpage>1022</fpage>
          &#x02013;<lpage>1030</lpage>. (<pub-id pub-id-type="doi">10.1212/WNL.0000000000002464</pub-id>
          )<pub-id pub-id-type="pmid">26888987</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
